Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Proteomic Identification of Small Extracellular Vesicle Proteins LAMB1 and Histone H4 for Prostate Cancer Diagnosis and Risk Stratification.

  • Authors : Pang B; Department of Urology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315010, China.; Ningbo Clinical Research Centre for Urological Disease, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315010, China.

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnosis ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Jun; Vol. 11 (23), pp. e2402509. Date of Electronic Publication: 2024 Apr 08.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

تفاصيل العنوان

×
Academic Journal

Network models of prostate cancer immune microenvironments identify ROMO1 as heterogeneity and prognostic marker.

  • Authors : Wang L; College of Life Sciences, Xinyang Normal University, Xinyang, 464000, China. .; College of Medicine, Xinyang Normal University, Xinyang, 464000, China. .

Subjects: Gene Regulatory Networks* ; Genetic Heterogeneity*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics

  • Source: Scientific reports [Sci Rep] 2022 Jan 07; Vol. 12 (1), pp. 192. Date of Electronic Publication: 2022 Jan 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Exploration of Redox-Related Molecular Patterns and the Redox Score for Prostate Cancer.

  • Authors : Wu Y; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030 Hubei, China.; Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030 Hubei, China.

Subjects: Oxidation-Reduction* ; Transcriptome* ; Tumor Microenvironment*

  • Source: Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2021 Nov 11; Vol. 2021, pp. 4548594. Date of Electronic Publication: 2021 Nov 11 (Print Publication: 2021).Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 101479826 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.

  • Authors : Su Q; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Medicine and Engineering, Beihang University, Beijing, China.; Clinical Laboratory Medicine, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.

Subjects: Nomograms* ; Transcriptome*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics

  • Source: Cancer medicine [Cancer Med] 2021 Sep; Vol. 10 (18), pp. 6492-6502. Date of Electronic Publication: 2021 Aug 28.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy.

  • Authors : Liu Z; Department of Urology, Minimally Invasive Surgery Center, Guangdong Key Laboratory of Urology, Guangzhou Urology Research Institute, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.; Zhong J

Subjects: RNA Processing, Post-Transcriptional* ; Tumor Microenvironment*; Adenosine/Adenosine/Adenosine/*analogs & derivatives

  • Source: Frontiers in immunology [Front Immunol] 2021 Aug 31; Vol. 12, pp. 735170. Date of Electronic Publication: 2021 Aug 31 (Print Publication: 2021).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

TP53 alterations of hormone-naïve prostate cancer in the Chinese population.

  • Authors : Liu Z; Department of Urology, Qilu Hospital of Shandong University, Ji'nan, 250012, PR China.; Key Laboratory of Urinary Precision Diagnosis and Treatment in Universities of Shandong, Ji'nan, 250012, PR China.

Subjects: Mutation*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; Neoplasms, Hormone-Dependent/Neoplasms, Hormone-Dependent/Neoplasms, Hormone-Dependent/*pathology

  • Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Jun; Vol. 24 (2), pp. 482-491. Date of Electronic Publication: 2020 Nov 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Pleiotropic Mechanisms Drive Endocrine Resistance in the Three-Dimensional Bone Microenvironment.

  • Authors : Dhimolea E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. .; Harvard Medical School, Boston, Massachusetts.

Subjects: Drug Resistance, Neoplasm*; Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/*pharmacology ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism

  • Source: Cancer research [Cancer Res] 2021 Jan 15; Vol. 81 (2), pp. 371-383. Date of Electronic Publication: 2020 Aug 28.Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C.

  • Authors : Zhang Y; Cancer Institute, Department of Urology, The Second Hospital of Dalian Medical University; Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism ; Nuclear Proteins/Nuclear Proteins/Nuclear Proteins/*metabolism ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*genetics

  • Source: Cell death & disease [Cell Death Dis] 2021 Jan 05; Vol. 12 (1), pp. 12. Date of Electronic Publication: 2021 Jan 05.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Immune-related biomarker risk score predicts prognosis in prostate cancer.

  • Authors : Liu Z; Department of Urology, Minimally Invasive Surgery Center, Guangdong Key Laboratory of Urology, Guangzhou Urology Research Institute, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.; Zhong J

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*immunology ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*diagnosis ; Prostatic Neoplasms/Prostatic Neoplasms/Prostatic Neoplasms/*immunology

  • Source: Aging [Aging (Albany NY)] 2020 Nov 10; Vol. 12 (22), pp. 22776-22793. Date of Electronic Publication: 2020 Nov 10.Publisher: Impact Journals, LLC Country of Publication: United States NLM ID: 101508617 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.

  • Authors : Chen C; Guangdong Provincial Institute of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China.

Subjects: Drug Resistance, Neoplasm*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism ; Docetaxel/Docetaxel/Docetaxel/*pharmacology

  • Source: BMC cancer [BMC Cancer] 2020 Apr 06; Vol. 20 (1), pp. 289. Date of Electronic Publication: 2020 Apr 06.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

×
  • 1-10 of  587 نتائج ل ""Liu Z""